SPOR Evidence Alliance (OST Partner), Gets Funding From World Health Organization

This is another look at the Ontario Science Table, and their partners. Now we get to the SPOR Evidence Alliance, which was supported by CIHR, the Canadian Institutes for Health Research. SPOR itself is an acronym for “Strategy for Patient Oriented Research”. Okay, it’s funded by the Canadian Government, but by itself, that isn’t too bad.

Problem is, SPOR is also supported and sponsored by, the World Health Organization, although the distinction isn’t clear. It’s also sponsored by CADTH, the Canadian Agency for Drugs and Technologies in Health, a WHO Working Group.

How We Manage Conflicts of Interests
-We currently DO NOT accept any funding from private industry (e.g., pharmaceutical companies, medical device manufacturers) to support our research activities.
-All our members must declare annual statements of conflicts and competing interests.
We encourage and nurture open communication and respectful relationships, and strive to resolve conflicts and competing interests through diplomacy.

While this sounds fine on paper, it overlooks 2 details. First, Governments, supra-national bodies and academia “can” and often do have conflicts of interest. Second, even if they don’t have conflicts of interests, groups they partner with can.

SPOR has more sponsors. This includes the University of Toronto, which has all kinds of ties to the Ontario Science Table. Furthermore, it’s sponsored by McMaster University, which hosts Cochrane Canada (another WHO partner), and receives money from the Bill & Melinda Gates Foundation.

At a Glance
The Strategy for Patient-Oriented Research (SPOR) Evidence Alliance is a pan-Canadian research initiative designed to promote evidence-informed health policy and practice changes. Our 300+ network of researchers, trainees, patient partners, and stakeholders is led by Dr. Andrea Tricco and 11 principal investigators from across Canada.

The SPOR Evidence Alliance was founded in 2017, thanks to a five-year grant awarded by the Canadian Institutes of Health Research (CIHR) under Canada’s SPOR Initiative, and the generosity of partners from 41 sponsors from public and not-for-profit sectors in Canada.

From this description, SPOR seems to present itself as a researching and consulting group, one designed to cause systematic change to health care. How many of these groups are there?

And when they take money from institutions like the World Health Organization, how independent can they really be?

Also, CIHR funds initiatives that seem to run counter to independence, like paying groups to act as vaccine salesmen and improve uptake rates. How independent is this group, or any part of the Canadian Government?

(1) https://sporevidencealliance.ca/
(2) https://sporevidencealliance.ca/about/governance-structure/
(3) https://sporevidencealliance.ca/wp-content/uploads/2021/04/SPOREA_Alliance-Infographic.pdf
(4) https://cihr-irsc.gc.ca/e/193.html
(5) https://cihr-irsc.gc.ca/e/41204.html

(a) Michael Warner Financially Benefits From Prolonged Lockdowns
(b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
(c) OST, Monopoly From The University Of Toronto Connected
(d) OST, University Of Toronto, Look At Their Members And Partners
(e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
(f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
(g) OST UofT Prelude Actually Set Out In May 2019
(h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
(i) OST: Como Foundation Gives Trillium Health Partners $5M
(j) OST: Current PHO Officials Also Sitting On As Partners
(k) OST: Canadian Agency For Drugs & Technologies In Health; pCPA
(l) OST: Centre For Effective Practice Gets Money From Lockdown
(m) OST: Cochrane Canada; WHO; McMaster University

Cochrane Canada: WHO Partner; OST Partner; McMaster University Affiliate

Cochrane Canada is listed as a partner for the Ontario Science Table. However, there are important things about this organization that are not being publicly discussed. For starters, Cochrane is partnered with the World Health Organization, and receives funding from them. Cochrane (the parent org) also gets funding from various Governments and universities.

What is the end result of this? Cochrane helps to legitimize the actions of the very Governments that it gets funded from. After all, it refuses to accept commercial funding.

It’s a bit like the 2003 Iraq war. U.S. Government Officials leaked their “information” to various journalists. Those journalists were then cited as sources to show there were weapons of mass destruction.

Cochrane is for anyone interested in using high-quality information to make health decisions. Whether you are a doctor or nurse, patient or carer, researcher or funder, Cochrane evidence provides a powerful tool to enhance your healthcare knowledge and decision making.

Cochrane’s members and supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, and people passionate about improving health outcomes for everyone, everywhere. Our global independent network gathers and summarizes the best evidence from research to help you make informed choices about treatment and we have been doing this for 25 years.

We do not accept commercial or conflicted funding. This is vital for us to generate authoritative and reliable information, working freely, unconstrained by commercial and financial interests.

Cochrane appears to have legitimacy, because it only takes money from Government or academic sources. But then it publishes material that validates the actions and conclusions of those very parties. It’s pay-for-play, but with very serious consequences.

The largest single donor to Cochrane is the National Institute for Health Research in the UK. But it’s worth pointing out that the World Health Organization is high up on that list.

More than 1 million GBP

  • National Institute for Health Research (NIHR) (UK)
  • Danish Health Authorities (Denmark)
  • National Institutes of Health (USA)

500k to 1 million GBP

  • Federal Ministry of Health (Germany)

100k to 500k GBP

  • South African Medical Research Council
  • Anonymous non‐profit organizations (charitable donations or commissioned work)
  • Department for International Development (UK)
  • Cochrane Charity ‐ central funds awarded
  • National Health and Medical Research Council (Australia)
  • Chief Scientist Office (Scotland)
  • World Health Organization
  • McMaster University (Canada)
  • Norwegian Agency for Development Cooperation (Norway)
  • Ministry of Health (New Zealand)
  • Ministry of Health, British Columbia (Canada)
  • Lower Austrian Health and Social Fund (Austria)
  • Laura & John Arnold Foundation
  • South African Department of Health
  • Institut national du Cancer (France)

50k to 100k GBP

  • Ministry of Health (Austria)
  • laurence le cleach (France)
  • HSC Research and Development (Northern Ireland)
  • Ministerio de Sanidad, Servicios Sociales e Igualdad/Ministry of Health, Social Services and Equality (Spain)
  • Joint Research Centre (Italy)
  • Vermont Oxford Network
  • Swiss Medical Board
  • Ministry of Health and Welfare (Taiwan)
  • The Gerber Foundation
  • Ciber de Epidemiología y Salud Pública (Spain)
  • Centre for Future Health, University of York / Wellcome (UK)
  • The National Health Research Institutes (Taiwan)
  • Skåne University Hospital (Sweden)

20k to 50k GBP

  • National Research Foundation (South Africa)
  • Federal Ministry of Education and Research (Germany)
  • University of Vermont, Larner College of Medicine (USA)
  • Liverpool School of Tropical Medicine (South Africa)
  • Cochrane Oral Health Global Alliance
  • Lund University (Sweden)
  • Federal Ministry of Education (Nigeria)
  • National Institute for Medical Research Development (Iran)
  • European Respiratory Society
  • Farncombe Family gift
  • Canadian Rheumatology Association
  • The Global Fund
  • Northumberland, Tyne and Wear NHS Foundation Trust (
  • UK)

  • Monash University (Australia)
  • University of York (UK)
  • Ministry of Science and Technology (Taiwan)
  • Institut de Recerca de Sant Pau (Spain)
  • Public Health Wales
  • Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) (Spain)
  • Kazan Federal University Program, Federal Ministry of Education and Science (Russia)
  • Universidad Francisco de Vitoria (Spain)
  • Dr. Peter Tugwell University Account (Canada)
  • Hamilton Health Sciences
  • State of Lower Austria
  • Lazio Region (Italy)
  • Universidad Tecnológica Equinoccial (Ecuador)
  • Niederösterreich Gesundheits und Sozialfonds (NOGUS)/Health and Social Funds, Lower Austria (Austria)
  • Odense University Hospital, University of Southern Denmark
    Canadian Association of Gastroenterology (Canada)
  • Anonymous non‐profit organization (charitable donation)
  • 10k to 20k GBP

    • American College of Gastroenterology (USA)
    • Navarre Health Service (Spain)
    • Foundation IRCCS ‐ Istituto Neurologico Carlo Besta, Milan (Italy)
    • Federal Ministry of Health (Nigeria)
    • University of Pécs (Hungary)
    • Campbell Collaboration
    • Economic and Social Research Council (UK)
    • Workshop 2018/2019
    • Medical Center – University of Freiburg (Germany)
    • Training (self‐funded)
    • Erasmus University (Netherlands)
    • Faculty of Medicine and Health Sciences, Stellenbosch University (South Africa)
    • Ministry of Health and Regione Lombardia (Italy)

    0.5k to 10k GBP

    • University Hospital Gaetano Martino Messina (Italy)
    • Faculdade de Medicina de Lisboa (Portugal)
    • Region Skåne (Sweden)
    • University of Copenhagen (Denmark)
    • MDS Foundation (Portugal)
    • Mapi Research Trust
    • CHU de Québec ‐ université Laval research center: Population Health and Optimal Health Practices (Canada)
    • Canada research chair critical care neurology and trauma (Canada)
    • Instituto Universitario Hospital Italiano (Italy)
    • Jagiellonian University Medical College (Poland)
    • University of the Basque Country (Spain)
    • Cochrane Canada
    • National Insitute for Clincal Excellence (NICE) (UK)
    • University of Split, School of Medicine (Croatia)
    • Cochrane Japan (commissioned work)
    • Cochrane Response
    • Ministry of Science and Education (Croatia)
    • Pan American Health Organization (PAHO)
    • City of Zagreb (Croatia)
    • Motor Neurone Disease Association (UK)
    • RCSI & UCD Malaysia Campus (formerly Penang Medical College) (Malaysia)
    • John Wiley & Sons, Ltd
    • Center for Primary Care and Public Health (Unisanté), Lausanne, Switzerland (formerly Institute of Social and Preventive Med
    • German Academic Exchange Service (DAAD)
    • City of Split (Canada)
    • Split‐Dalmatia County (Croatia)
    • Croatian Academy of Sciences and Arts

    Less than 500 GBP

    • Center for Reproductive Medicine (Netherlands)
    • Health Authority, Umbria Region (Italy)

    As for the operation of Cochrane Canada, it is tied to McMaster University in Hamilton, Ontario. In fact, several people have an interest in that school.

    McMaster is a major donor to Cochrane, as is the British Columbia Ministry of Health.

    In 2016, the Michael G. DeGroote Cochrane Canada Centre formalized a move from the Ottawa Hospital Research Institute (OHRI) to its original home of McMaster University – widely acknowledged as the home of evidence-based medicine.

    The Centre supports Cochrane initiatives across the country by conducting education activities, functioning as the communications and knowledge brokering lead for Cochrane Canada, and advocating for the use of evidence in decision-making within Canada.

    Link to search IRS charity tax records:

    Let’s clarify here: there are actually 2 separate entities. The Foundation is the group that distributes money to various organizations and institutions. The Foundation Trust, however, is concerned primarily about asset management.

    EIN: 56-2618866

    EIN: 91-1663695

    Above are records from the Bill & Melinda Gates Foundation. The records are publicly available with the IRS. The top is from the year 2017, and the bottom 2018.

    McMaster claimed to have isolated the virus that causes Covid-19. That’s very interesting, considering that when Fluoride Free Peel did a freedom of information request for it, there were no records available.

    $21 million from the Gates Foundation since 2015, according to their publications. Is McMaster University an institution we can trust, or has it been corrupted by special interest money and ideology?

    Also, is Cochrane (either Cochrane Canada, or the parent organization) something that we can trust? Or is it just helping conceal the intentions of interested parties?

    (1) https://covid19-sciencetable.ca/our-partners/
    (2) https://covid19-sciencetable.ca/our-partners/
    (3) https://esnetwork.ca/
    (4) https://www.cochrane.org
    (5) https://www.cochrane.org/about-us/our-funders-and-partners
    (6) https://canada.cochrane.org/about-us/micheal-g-degroote-cochrane-canada-centre
    (7) https://apps.irs.gov/app/eos/
    (8) https://healthsci.mcmaster.ca/home/2020/03/13/mcmaster-researcher-plays-key-role-in-isolating-covid-19-virus-for-use-in-urgent-research
    (9) https://www.fluoridefreepeel.ca/university-of-toronto-sunnybrook-hsc-have-no-record-of-covid-19-virus-isolation/
    (10) https://www.gatesfoundation.org/about/committed-grants/2019/11/inv003448
    (11) https://www.gatesfoundation.org/about/committed-grants/2019/11/inv003448
    (12) https://www.gatesfoundation.org/about/committed-grants/2015/06/opp1129405
    (13) https://www.gatesfoundation.org/about/committed-grants?q=mcmaster%20#jump-nav-anchor0

    (a) Michael Warner Financially Benefits From Prolonged Lockdowns
    (b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
    (c) OST, Monopoly From The University Of Toronto Connected
    (d) OST, University Of Toronto, Look At Their Members And Partners
    (e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
    (f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
    (g) OST UofT Prelude Actually Set Out In May 2019
    (h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
    (i) OST: Como Foundation Gives Trillium Health Partners $5M
    (j) OST: Current PHO Officials Also Sitting On As Partners
    (k) OST: Canadian Agency For Drugs & Technologies In Health; pCPA
    (l) OST: Centre For Effective Practice Gets Money From Lockdown

    Centre For Effective Practice, Yet Another OST “Partner” That Stands To Profit From Lockdowns

    The Centre for Effective Practice, or CEP, is another “partner” of the Ontario Science Table. The OST apparently does the thinking for Doug Ford and Christine Elliott.

    Unsurprisingly, CEP was established as part of the University of Toronto in 2004. They list their services as: research & evaluation, clinical tools and digitization, education programs, and engagement & communication.

    CEP also provides a set of key talking points that doctors and other health care providers are to parrot concerning these “vaccines” now available in Canada. The goal isn’t to address legitimate concerns, but rather, to appear to be addressing them.

    COVID-19 vaccine authorization
    Health Canada has authorized a number of COVID-19 vaccines for use in Canada after a thorough and rigorous review of the evidence to ensure the vaccines meet the standards of safety, quality and efficacy for authorization in Canada. Health Canada will continue to monitor the safety of the vaccines after they are available.

    Key messages
    Lead by example. Get the COVID-19 vaccine yourself as soon as it is offered to you to protect yourself, your patients, and your community.
    Advise patients to receive the vaccine. Communication by trusted health professionals about the importance of vaccines is the most effective way to counter vaccine hesitancy. Tell your patients you will get or have already received the vaccine.
    -Be an educator. Be prepared to answer patient questions and address concerns about the vaccine.

    Vaccine summary
    Efficacy against severe disease and hospitalization
    -All of the approved vaccines have a high efficacy rate against severe disease. In the clinical trials, efficacy against severe disease was shown to be:

    Pfizer: 75-100% (after dose 2)
    Moderna: 100% (14 days after dose 2)
    AstraZeneca: 100% (after dose 2)
    Janssen: 85.4% (28 days after dose)

    First, whether by accident, or by design, CEP is blurring the line between “approved” vaccines, and ones given “interim authorization”. To clarify, these are not approved. Section 30.1 of the Canada Food & Drug Act allows the Health Minister to sign an Interim Order, allowing them on the market anyway.

    (a) Approved: Health Canada has fully reviewed all the testing, and steps have been done, with the final determination that it can be used for the general population
    (b) Interim Authorization: deemed to be “worth the risk” under the circumstances, doesn’t have to be fully tested. Allowed under Section 30.1 of the Canada Food & Drug Act. Commonly referred to as an emergency use authorization.

    Have a look at the Interim Order, particularly Section 5. Getting authorization isn’t exactly a difficult burden to meet.

    Second, an astute person will notice the sleight-of-hand here. These so-called vaccines were “authorized” by Health Canada, however “approved” ones will be rigorously tested. This is an indirect way of saying that these weren’t actually subjected to such testing.

    Third, these aren’t really vaccines. Gene replacement therapy would be a more accurate description of the mRNA substances that Pfizer and Moderna produced.

    Fourth, it doesn’t say that these gene-replacement “vaccines” will prevent a virus. Instead, it touts efficacy against severe disease and hospitalization. In other words, symptom management.

    Fifth, it is explicitly stated that people will rely on your opinion in order to make the decision. While it’s also stated to answer questions, this passage is full of misrepresentations.


    Instead of taking word of someone on the internet, it’s probably best to read the product inserts for yourself. Above are the documents provided by Health Canada. Notice, that nowhere do they say “approved” in the documentation.

    However, CEP doesn’t provide the actual Health Canada documents. They do other an AstraZeneca summary and a comparison paper, but not the original source materials

    Now, why why CEP, the Centre for Effective Practice, be such a blatant shill in the name of big pharma? When you look at their donors and collaborators, things start to make a lot of sense.

    Some of CEP’s financial contributors, associates are worth a closer look:

    1. Association of Family Health Teams of Ontario
    2. eHealth Centre of Excellence
    3. Healthcare Excellence Canada
    4. OntarioMD

    Could it be that CEP, and its partners and donors support continued lockdowns and restrictions in Ontario, (and elsewhere), at least partially because it’s good for business? Let’s take a look into some of these groups.

    We Are The Advocate, Network And Resource For Team-Based Primary Care In Ontario
    The Association of Family Health Teams of Ontario (AFHTO) works to support the implementation and growth of primary care teams by promoting best practices, sharing lessons learned, and advocating on behalf of all primary care teams. Evidence and experience show that team-based comprehensive primary care is delivering better health and better value to patients.
    AFHTO is a not-for-profit association representing Ontario’s primary health care teams, which include Family Health Teams (FHTs), Nurse Practitioner-Led Clinics (NPLCs) and others who provide interprofessional comprehensive primary care.
    Working towards a common vision
    Our members share the compelling vision that one day, all Ontarians will have timely access to high-quality and comprehensive primary care; care that is:
    Informed by the social determinants of health – the conditions in which people are born, grow, live, work and age
    Delivered by the right mix of health professionals, working in collaborative teams in partnership with patients, caregivers and the community
    Anchored in an integrated and equitable health system, promoting good health and seamless care for all patients
    Sustainable – efficiently delivered and appropriately resourced to achieve expected outcomes

    AFHTO works with and on behalf of members to:
    Provide leadership to promote expansion of high-quality, comprehensive, well-integrated interprofessional primary care for the benefit of all Ontarians, and
    Be their advocate, champion, network and resource to support them in improving and delivering optimal interprofessional care

    The Association of Family Health Teams of Ontario is essentially a lobbying group, for the unmbrella of health care workers. That’s what this word salad means. AFTHO also is quite partisan in their efforts, and are pushing for the virtual care model of health, a large part of their online content covers that.

    AFHTO is also demanding Ford impose a stay-at-home order. This is a conflict of interest since they are also promoting the “solution”: more access to online health services.

    The eHealth Centre of Excellence is another online medical service that offers e-prescribing, referrals, and consults with specialists. As continued lockdowns make physical movement more tricky, this enterprise will surely grow. Also, as the physical and mental health of people wears down, it will artificially generate more business.

    Healthcare Excellence Canada acts as a cross between a health care consultant, and an continuing education provided. They also donate to CEP, and their business model is expected to grow. Also, if you wish to take their Executive Training Program, it’s only $2,500 to enroll. What a deal!

    OntarioMD offers a variety of services, such as digital health services, which can be bundled together. There’s also eConsulting, which aims to connect patients to specialists quicker. There’s also a Health Medical Upgrade, which is a way of digitizing, storing, and moving records. As physical appearances in health care settings are replaced, the demand for this will grow.

    It’s worth pointing out that OntarioMD is not the only party to benefit from this arrangement. Additionally, it means increased business for its vendors, who will also see the rewards. Some of these names should be familiar.

    To circle back to the start of the article: what is the real reason that the Centre for Effective Practice, (an Ontario Science Table partner), is so on board with restrictions to liberty? Or, are these connections just coincidental, and completely unrelated?

    (1) https://cep.health/
    (2) https://cep.health/toolkit/covid-19-resource-centre/
    (3) https://tools.cep.health/tool/covid-19-vaccines/
    (4) https://tools.cep.health/tool/covid-19-vaccine-staging-environment/
    (5) https://tools.cep.health/tool/virtual-management-of-chronic-conditions-during-covid-19/
    (6) https://covid19-sciencetable.ca/our-partners/
    (7) https://twitter.com/Roman_Baber/status/1386788379669508103
    (8) Ontario Science Table 01 Behaviour Control Techniques April 22 2021
    (9) Ontario Science Table 02 Vaccine Confidence March 5 2021
    (10) Ontario Science Table 03 Learning From Israel Feb 1 2021
    (11) Ontario Science Table 04 Putting In Harsher Restrictions Oct 15 2021
    (12) https://www.laws-lois.justice.gc.ca/eng/acts/F-27/page-8.html#h-234517
    (13) Patty Hajdu’s September 16 Interim Order
    (14) CEP AstraZeneca Information Propaganda
    (15) CEP Vaccine Comparison Sheet Propaganda
    (16) https://www.afhto.ca/
    (17) https://www.afhto.ca/afhtos-role-supporting-team-based-care/about-afhto
    (18) https://www.afhto.ca/news-events/news/ontario-needs-stay-home-order
    (19) AFHTO Shift To Virtual Health Care
    (20) https://ehealthce.ca/Our-Team.htm
    (21) https://healthcareexcellence.ca/
    (22) Health Care Excellence Executive Training Class
    (23) https://www.ontariomd.ca/
    (24) https://www.ontariomd.ca/about-us/our-organization/our-partners

    (a) Michael Warner Financially Benefits From Prolonged Lockdowns
    (b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
    (c) OST, Monopoly From The University Of Toronto Connected
    (d) OST, University Of Toronto, Look At Their Members And Partners
    (e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
    (f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
    (g) OST UofT Prelude Actually Set Out In May 2019
    (h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
    (i) Como Foundation Gives Trillium Health Partners $5M
    (j) Current PHO Officials Also Sitting On Ontario Science Table
    (k) Canadian Agency For Drugs & Technologies In Health; pCPA

    OST; WHO; Canadian Agency for Drugs and Technologies in Health (CADTH), Pan-Canadian Pharmaceutical Alliance

    The Canadian Agency for Drugs and Technologies in Health (CADTH), is a partner of the Ontario Science Table, or OST. However, CADTH is also a working group for the World Health Organization, Health Evidence Network. Now, OST “claims” to be a neutral and independent body giving scientific and medical advice. Question, is CADTH compromised, or can this do really serve 2 (or more) masters?

    The Health Evidence Network describes itself in the following way:

    Recognizing that public health, health care and health systems policy-makers need access to timely, independent and reliable health information for decision-making, WHO/Europe started HEN in 2003. It acts as a platform, providing evidence in multiple formats to help decision-making.

    The Health Evidence Network also claims to be independent, much the way OST does. Interestingly, they always have the exact same recommendations to make.

    Previously Theresa Tam got flack for being on a World Health Organization Committee, while simultaneously claiming to represent Canada as the Public Health Officer. It seems these kinds of conflicts of interest are normal, and not the exception.

    CADTH, the Canadian Agency for Drugs and Technologies in Health, claims to be an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

    Created in 1989 by Canada’s federal, provincial, and territorial governments, CADTH was born from the idea that Canada needs a coordinated approach to assessing health technologies. The result was an organization that harnesses Canadian expertise from every region and produces evidence-informed solutions that benefit patients in jurisdictions across the country.

    CADTH claims to be independent, just like OST claims to be independent. The WHO Health Evidence Network also says that it’s an independent entity. Keep that in mind, as it will become important later on. Now, who actually runs CADTH?

    • David Agnew: held the position of President and CEO of UNICEF Canada, and was the first head of the organization recruited from outside the international development sector. He is the past Chair of Sunnybrook Health Sciences Centre and of Colleges Ontario. He also serves on numerous other boards and committees, including the Toronto Region Immigrant Employment Council, the Council on Foreign Relations’ Higher Education Working Group on Global Issues, the Sichuan University International Advisory Board, the CivicAction Steering Committee and the Canadian Ditchley Foundation Advisory Board. He is a former member of the federal government’s Science, Technology, and Innovation Council, a former director of ventureLAB and the Empire Club of Canada, and has served on the campaign cabinets of the United Way in Toronto and Peel.
    • Marcel Saulnier, Associate Assistant Deputy Minister, Strategic Policy Branch, Health Canada
    • Western Provinces, Mitch Moneo, Assistant Deputy Minister, Pharmaceutical Services Division, Ministry of Health, British Columbia
    • Mark Wyatt, Assistant Deputy Minister, Saskatchewan Ministry of Health
    • Territories, Stephen Samis, Deputy Minister, Health and Social Services, Government of Yukon
    • Ontario, Patrick Dicerni, Assistant Deputy Minister, Drugs and Devices Division and Executive Officer, Ontario Public Drug Programs
    • Atlantic Provinces, Jeannine Lagassé, Associate Deputy Minister of Health and Wellness, Province of Nova Scotia.
    • Karen Stone, Deputy Minister of Health and Community Services (NL)
    • Health Systems, Dr. Brendan Carr, President and CEO of the Nova Scotia Health Authority

    The Board of Directors of CADTH primarily is made up of high level bureaucrats in Canada, such as Associate Deputy Ministers. Far from being independent, this board is in fact connected to Provincial and Federal Governments.

    • drugs
    • diagnostic tests
    • medical, dental, and surgical devices and procedures

    CADTH makes recommendations whether to accept certain medical devices and procedures. They also make recommendations on pharmaceuticals. This is interesting, considering that they don’t seem to do any research themselves. In fact, looking up the term “gene therapy” nets a lot of results.

    Strange, because aren’t the Pfizer and Moderna mRNA “vaccines” really just a form of gene replacement therapy? It seems this technology has been around for a while.

    Although this may seem harmless enough, there is another aspect to what these Provincial bureaucrats are doing. It’s not only that they want to review and make recommendations, but they want to PROMOTE cheap pharmaceuticals as well.

    The pan-Canadian Pharmaceutical Alliance (pCPA) is an alliance of the provincial, territorial and federal governments that collaborates on a range of public drug plan initiatives to increase and manage access to clinically effective and affordable drug treatments.

    One of pCPA’s key roles is to conduct joint negotiations for brand name and generic drugs in Canada in order to achieve greater value for publicly funded drug programs and patients through its combined negotiating power. Its objectives are to:

  • increase access to clinically effective and cost-effective drug treatment options;
  • achieve consistent and lower drug costs for participating jurisdictions;
  • reduce duplication of effort and improve use of resources; and
  • improve consistency of decisions among participating jurisdictions.
  • (Alberta) Chad Mitchell, Assistant Deputy Minister
    (British Columbia) Mitch Moneo, Assistant Deputy Minister (Vice-Chair, Acting)
    (Manitoba) Teresa Mrozek, (A) Assistant Deputy Minister
    (New Brunswick) Mark Wies, Assistant Deputy Minister
    (Newfoundland & Labrador) John McGrath, (A) Assistant Deputy Minister
    (Northwest Territories) Derek Elkin, Assistant Deputy Minister
    (Nova Scotia) Natalie Borden, Executive Director
    (Nunavut) Donna Mulvey, Territorial Director
    (Ontario) Patrick Dicerni, Assistant Deputy Minister; Executive Officer
    (Prince Edward Island) Lori Ellis, Director of Health Workforce Planning and Pharmacy
    (Quebec) Lucie Opatrny, Assistant Deputy Minister
    (Saskatchewan) Mark Wyatt, Assistant Deputy Minister (Chair)
    (Yukon) Amy Riske, Assistant Deputy Minister
    (Federal) Scott Doidge, Director General

    Notice anything? Just like with CADTH, the pan-Canadian Pharmaceutical Alliance is also run by top bureaucrats in the Governments. In fact, Mitch Moneo of B.C., and Mark Wyatt of Saskatchewan sit on both groups. the goal of this group is getting cheap, generic drugs available to all Canadians.

    Now, these bureaucrats, and their colleagues, are also involved with the Canadian Agency for Drugs and Technologies in Health, which approves drugs, procedures, and medical devices.

    And CADTH is a partner of the Ontario Science Table, which is pushing: mass vaccination, drugs for other health issues, mandatory masks, and lockdowns which will drive up the use of internet and virtual health care.

    The pCPA site explains the process like this:
    Health Canada reviews the drugs, which is not the same as actually testing them. Then CADTH and INESSS (the Quebec counterpart), review it to see if this is a cost effective way to go. Then pCPA tries to negotiate for cheaper and more affordable drug prices. Eventually it gets worked into public and private drug plans.

    Back to the original point: the Ontario Science Table claims to be an independent group. But it’s partnered with (among others) CADTH, who plays a major role in advancing big pharma in Canada.

    (a) https://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/health-evidence-network-hen/technical-members/current-technical-members/canadian-agency-for-drugs-and-technologies-in-health-cadth,-canada
    (b) https://covid19-sciencetable.ca/our-partners/
    (c) https://www.cadth.ca/about-cadth
    (d) https://www.cadth.ca/about-cadth/who-we-are/board-of-directors
    (e) https://www.pcpacanada.ca/
    (f) https://www.pcpacanada.ca/governance
    (g) https://www.pcpacanada.ca/faq
    (h) https://www.pcpacanada.ca/about

    (a) Michael Warner Financially Benefits From Prolonged Lockdowns
    (b) Who Is Ontario Deputy Medical Officer, Barbara Yaffe?
    (c) OST, Monopoly From The University Of Toronto Connected
    (d) OST, University Of Toronto, Look At Their Members And Partners
    (e) OST’s Robert Steiner Claims To Be Behind PHAC Canada Creation
    (f) OST’s Kwame McKenzie Headed 2017 UBI Pilot Project
    (g) OST UofT Prelude Actually Set Out In May 2019
    (h) OST’s Murty Has Tech Firm That Benefits From Lockdowns
    (i) Como Foundation Gives Trillium Health Partners $5M
    (j) Current PHO Officials Also Sitting On Ontario Science Table

    Public Health Ontario A Semi-Autonomous Corporation, Whose Leaders Sit With ON Science Table

    According to the Ontario Agency for Health Protection and Promotion Act, 2007, the Ontario Agency for Health Protection and Promotion was created, which is now referred to as Public Health Ontario. The timing is interesting, given that its creation aligns with the 2005 Quarantine Act, which itself is the result of the 3rd Edition of the International Health Regulations from the World Health Organization.

    For some background information, here is more on the WHO-IHR, the Quarantine Act, and Ontario‘s own Health Act. It’s worth also addressing PHAC, and its self-proclaimed advisor, Robert Steiner, who also sits on OST. These are not independent events, but are directly linked.

    This entity (referred to as Public Health Ontario, or PHO), is set up and structured as a corporation. It’s a Crown Corporation, mostly autonomous from the Government.

    7 (1) Except as limited by this Act, the Corporation has the capacity, rights and powers of a natural person for carrying out its objects. 2007, c. 10, Sched. K, s. 7 (1).

    This group is to have the same rights and powers as an actual person which is not weird at all. The Act also indemnifies any employees or officers or directors from any liability, as long as they claim to be acting in good faith.

    No actions or proceedings against Crown
    26 No proceeding for damages or otherwise shall be commenced against the Crown, the Minister or any person employed by the Crown with respect to any act done or omitted to be done or any decision of the Corporation, a director or officer of the Corporation, a member of a standing committee or a person employed by the Corporation. 2007, c. 10, Sched. K, s. 26.

    Immunity from civil action
    27 (1) No proceeding for damages or otherwise shall be commenced against the Minister, a director or officer of the Corporation, a member of a standing committee, or any person employed by the Crown or the Corporation, with respect to any act done or omitted to be done or any decision under this Act that is done in good faith in the execution or intended execution of a power or duty under this Act. 2007, c. 10, Sched. K, s. 27 (1); 2011, c. 1, Sched. 6, s. 7 (1).

    Nothing shows that people take responsibility for their actions quite like giving them a pass for the possible consequences. There are limited provisions for taking action against the Crown itself, but not members involved.

    Anyhow, that Act specifies that this corporation is to act as an autonomous and mostly independent group from the Government. This would be similar to Alberta Health Services operates.

    Now, PHO is structured as a corporation, and is designed to be an arm’s length operation from the Crown. Okay. But looking at who runs it, some familiar faces appear.

    • Brian Schwartz is Vice President of PHO
    • Vanessa Allen is Chief, Microbiology and Laboratory Science at PHO
    • Jessica Hopkins, Chief Health Protection and Emergency Preparedness Officer at PHO
    • Samir Patel, Deputy Chief, Microbiology and Laboratory Science at PHO

    Some interesting names in the Leadership of Public Health Ontario. Why should we care about who any of them are? There’s a really simple reason.

    In case it wasn’t clear, here is the point: several high ranking members of Public Health Ontario are also members of the Ontario Science Table. Keep in mind, the OST presents itself as neutral and independent expert advice. At the same time, officials from a Crown Corporation in that same Province are part of their organization.

    Considering that PHO functions as an extension of the World Health Organization, and implements their dictates, what kind of perspectives will these people bring to OST? Will they simply implement the same ideas, cloaked as “science”, or will they offer radically different policies? So far, it seems to be the former.

    When these people speak at OST events and gatherings, are they talking as scientists working independently for the health of Ontarians overall? Or, are they acting in the capacity of Public Health Ontario representatives? Unless the OST is an extension of PHO, there are bound to be conflicts of interest.

    It’s a bit like Theresa Tam, who has a page as the Public Health Officer of Canada, but who also as a page for a World Health Organization Advisory Committee. These people even use the same photographs.

    On a related note: Deputy Prime Minister, and Finance Minister, Chrystia Freeland is also a Trustee at the World Economic Forum. Other prominent politicians are also involved with that organization.

    The mess that is the covered before, and more is likely to be added. Far from being independent, OST is rotten to the core with conflicts of interests, and members who have side ventures.

    Do the OST and Trillium Health Partners really think that mask mandates are in the public’s best interest? Or did a $5 million donation from a mask manufacturer change their minds? Does Michael Warner‘s side business influence his support for lockdowns? What About Kumar Murty‘s business interests? Or Kwame McKenzie‘s 2017 Ontario UBI project?

    Final thoughts to readers in Ontario: do you have any clue who is really running health care in Ontario? Do you know who is actually running the Province? Who’s behind the martial law masked as medical necessity? Think Doug Ford or Christine Elliott are anything but puppets?

    Trillium Health Partners Gets $5 Million Grant From Company That Manufactures Face Masks

    Robert Reid is a member of the Ontario Science Table. He is also on the Senior Leadership Team of Trillium Health Partners. This is important because it sets up an interesting conflict of interest.

    Trillium is also a partner with the OST. So, when Reid is speaking, does he talk as a member of THP, or of the OST?

    For some perspective, the OST is already a questionable organization given: (a) rampant ties the the University of Toronto; (b) conflicts of interest with its partners and members; (c) the brainchild of PHAC works for them; (d) the former research chief of the Ontario UBI pilot project works for them; (e) the groundwork for OST was laid out in 2019; and (f) another member has a technology business that benefits from lockdowns.

    Ontario Deputy Medical Officer, Barbara Yaffe, is worth a long hard look. She has climbed the ranks and gained power, despite never practicing as a doctor. Another one is Michael Warner, who financially benefits from prolonged lockdowns. It’s also disturbing that NSERC/CIHR are actually paying people to act as vaccine salesmen, and cloak it as research.

    Now, what does all of this have to do with Reid and Trillium? On the surface, it looks like OST’s policies are once again being influenced by special interests. Back in September 2020, word of a $5 million donation from the Como Foundation was announced to the public.

    Mississauga, On (September 28, 2020) – When the pandemic hit, Max Cucchiella and his wife, Sarah Veinot, along with their family, gathered around the kitchen table in their Port Credit home to help their community. They started making non-medical masks with a clear vinyl insert in the centre, so that those who are deaf or hard of hearing and rely on lip-reading could rejoin the conversation during COVID-19. The lip-reading lens mask, called My Access Mask, is continually evolving with a commitment to quality, innovation and design. Demand took off and the family launched the Como Foundation, which today is announcing a $5 million gift to Trillium Health Partners Foundation with proceeds from mask sales. The generous donation will be used to support the redevelopment and expansion of Mississauga Hospital.

    The gift is the result of local innovation, benefitting not just those who are deaf or hard of hearing and Trillium Health Partners (THP), but also McRae Imaging, a local medium-sized business hurt by lost revenue as a result of COVID-19. McRae is now producing these novel masks at a commercial volume in Ontario and is listed on the province’s Workplace PPE Supplier Directory.

    How much is the mask industry thriving when a company can afford to cut a $5 million cheque, based on the proceeds from the last 8 months or so? Trillium Health Partners becomes relevant when you realize they are one of Ontario Science Table’s Partners. Not only is Robert Reid in management for THP, but he’s part of the OST as well. Trillium and Reid are in a position to press the Province for mask mandates.

    According to the Canada Revenue Agency, there are in fact 2 charities: (i) Trillium Health Partners; and (ii) Trillium Health Partners Foundation. The first is the teaching hospital aspect, and in 2019, it had about $1.2 billion in revenue. The second is the fundraising arm, and in 2019, it raised about $20 million.

    There is also an interesting question that needs to be asked: was any consideration given to the Como Foundation in return for this $5 million donation? In the world of public fundraising, it’s a bad idea to do anything that would harm a donor’s business. And declaring an end to the “pandemic”, or even just mask mandates, would certainly dry up a large part of the Como Foundation’s revenue.

    The Como Foundation makes a specialized product: see-through masks to help with people who have disabilities read lips and understand better. While there is definitely a benefit to this, it would have been considered a niche market until about a year ago, when masks became mandated.

    What was once a limited business has suddenly exploded in growth, thanks almost entirely to politicians imposing mask mandates on the public. In fact, Como’s business is doing so well, that they can make a $5 million donation to one of the Ontario Science Table’s partner organizations.

    Also in September 2020, Doug Ford gave the company a public shoutout, saying that these products were absolutely necessary. Now, his Government, encouraged by the Ontario Science Table, supports mandatory masks for the foreseeable future.

    Considering Health Canada only authorized their product in June 2020, they seem to have done remarkably well.

    What do you think? Does this donation from Como to Trillium come with any conditions, or any “understandings”? Or is it just a coincidence?

    (a) https://covid19-sciencetable.ca/about/
    (b) http://trilliumhealthpartners.ca/aboutus/Pages/Seniorleadership.aspx
    (c) https://trilliumgiving.ca/press-releases/como-gift/
    (d) https://www.thecomofoundation.ca/
    (e) https://www.youtube.com/watch?v=EDhBOmG5ZIc
    (f) https://www.thecomofoundation.ca/healthcanada
    Como Foundation Mask Health Authorization June 2020